Why so many doses, and why now?
Saved in:
| Main Authors: | S Bilgic, B Akovalı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-06-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/14/3/ETJ-25-0115.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-01-01) -
Development and validation of a nomogram to predict failure of initial radioactive iodine therapy in differentiated thyroid cancer: a retrospective cohort study
by: Yulong Tang, et al.
Published: (2025-08-01) -
Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis
by: Congcong Wang, et al.
Published: (2025-08-01) -
POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01) -
Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer
by: Wang Y, et al.
Published: (2024-11-01)